Results 61 to 70 of about 1,519,271 (256)

Study on the Influence of Channel Characteristic on Carrier Phase Measurement Bias for GNSS Receiver

open access: yesIEEE Access
Global Navigation Satellite System (GNSS) has been widely used in transportation and agriculture areas due to its characteristics of high precise, all time and all weather.
Yaoding Wang, Xiang Fan
doaj   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Parallel Tracking Systems

open access: yes, 1995
Tracking Systems provide an important analysis technique that can be used in many different areas of science. A Tracking System can be defined as the estimation of the dynamic state of moving objects based on 'inaccurate’ measurements taken by sensors ...
Hulot, Carlos
core   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Incentives from Curriculum Tracking: Cross-national and UK Evidence [PDF]

open access: yes
Curriculum tracking creates incentives before its start, and we should expect scores in tested subjects to be higher at that point. I find evidence from both UK and international data for sizable incentive effects.
Koerselman, Kristian
core  

Mechatronics Application to Solar Tracking [PDF]

open access: yes, 2011
The purpose of this was to design and implement a two-axis solar tracking system utilizing the National Instruments C-Rio real time controller. In order to accomplish this a prototype was modeled in CAD. This prototype used two 12 V DC motors to change a
Rodriguez, Danny L, Jr
core  

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Radar Constant-Modulus Waveform Design with Prior Information of the Extended Target and Clutter

open access: yesSensors, 2016
Radar waveform design is of great importance for radar system performances and has drawn considerable attention recently. Constant modulus is an important waveform design consideration, both from the point of view of hardware realization and to allow for
Wenzhen Yue   +3 more
doaj   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy